1-Deoxynojirimycin derivatives from the marine sponge Lendenfeldia chondrodes

Journal of Antibiotics

Volumn 59, Issue 8, 2006, Pages 507-511

  Sakai, Ryuichi ^a   Kamiya, Hisao ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Deoxynojirimycin; Lendenfeldia; Marine sponge; glucosidase inhibitor

Indexed keywords

1 DEOXYNOJIRIMYCIN; 1 DEOXYNOJIRIMYCIN 6 PHOSPHATE; N METHYL 1 DEOXYNOJIRIMYCIN 6 PHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DEGRADATION; DRUG ISOLATION; FEDERATED STATES OF MICRONESIA; FUNGAL STRAIN; MARINE ENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; SPECTROSCOPY;

LENDENFELDIA; LENDENFELDIA CHONDRODES;

EID: 33749467054     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2006.71     Document Type: Article

References (24)

1. Yagi M, Kouno T, Aoyagi Y, Murai H. The structure of moranoline, a piperidine alkaloid from Morus species. Nippin Nougei Kagaku Kaishi 50: 571-572 (1976)
2. Tan A, van den Broek L, van Boeckel S, Ploegh H, Bolscher J. Chemical modification of the glucosidase inhibitor 1-deoxynojirimycin. Structure-activity relationships. J Biol Chem 266: 14504-14510 (1991)
3. Romero PA, Datema R, Schwarz RT. N-methyl-1-deoxynojirimycin, a novel inhibitor of glycoprotein processing, and its effect on fowl plague virus maturation. Virology 130: 238-242 (1983)
4. Mehta A, Carrouee S, Conyers B, Jordan R, Butters T, Dwek RA, Block TM. Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: therapeutic implications. Hepatology 33: 1488-1495 (2001)
5. Saito T, Yamaguchi I. Effect of glycosylation and glucose trimming inhibitors on the influenza A virus glycoproteins. J Vet Med Sci 62: 575-581 (2000)
6. Karlsson GB, Butters TD, Dwek RA, Platt FM. Effects of the imino sugar N-butyldeoxynojirimycin on the N-glycosylation of recombinant gp120. J Biol Chem 268: 570-576 (1993)
7. Gruters RA, Neefjes JJ, Tersmette M, de Goede RE, Tulp A, Huisman HG, Miedema F, Ploegh HL. Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase. Nature 330: 74-77 (1987)
8. van der Spoel AC, Jeyakumar M, Butters TD, Charlton HM, Moore HD, Dwek RA, Platt FM. Reversible infertility in male mice after oral administration of alkylated imino sugars: a nonhormonal approach to male contraception. Proc Natl Acad Sci USA 99: 17173-17178 (2002)
9. Andersson U, Smith D, Jeyakumar M, Butters TD, Borja MC, Dwek RA, Platt FM. Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease. Neurobiol Dis 16: 506-515 (2004)
10. Butters TD, Dwek RA, Platt FM. New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases. Adv Exp Med Biol 535: 219-226 (2003)
11. Cox TM, Aerts JM, Andria G, Beck M, Belmatoug N, Bembi B, Chertkoff R, Vom Dahl S, Elstein D, Erikson A, Giralt M, Heitner R, Hollak C, Hrebicek M, Lewis S, Mehta A, Pastores GM, Rolfs A, Miranda MC, Zimran A. The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement. J Inherit Metab Dis 26: 513-526 (2003)
12. Elstein D, Hollak C, Aerts JM, van Weely S, Maas M, Cox TM, Lachmann RH, Hrebicek M, Platt FM, Butters TD, Dwek RA, Zimran A. Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease. J Inherit Metab Dis 27: 757-766 (2004)
13. Jeyakumar M, Norflus F, Tifft CJ, Cortina-Borja M, Butters TD, Proia RL, Perry VH, Dwek RA, Platt FM. Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation. Blood 97: 327-329 (2001)
14. Jeyakumar M, Smith DA, Williams IM, Borja MC, Neville DC, Butters TD, Dwek RA, Platt FM. NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin. Ann Neurol 56: 642-649 (2004)
15. Sakai R, Kamiya H, Murata M, Shimamoto K. Dysiherbaine: A new neurotoxic amino acid from the Micronesian marine sponge Dysidea herbacea. J Am Chem Soc 119: 4112-4116 (1997)
16. Sakai R, Koike T, Sasaki M, Shimamoto K, Oiwa C, Yano A, Suzuki K, Tachibana K, Kamiya H. Isolation, structure determination, and synthesis of neodysiherbaine A, a new excitatory amino acid from a marine sponge. Org Lett 3: 1479-1482 (2001)
17. Sakai R, Oiwa C, Takaishi K, Kamiya H, Tagawa M. Dysibetaine: a New α-disubstityted α-amino acid derivative from the Marine Sponge Dysidea herbacea. Tetrahedron Lett 40: 6941-6944 (1999)
18. Sakai R, Suzuki K, Shimamoto K, Kamiya H. Novel betaines from a micronesian sponge Dysidea herbacea. J Org Chem 69: 1180-1185 (2004)
19. Asano N, Yamashita T, Yasuda K, Ikeda K, Kizu H, Kameda Y, Kato A, Nash RJ, Lee HS, Ryu KS. Polyhydroxylated alkaloids isolated from mulberry trees (Morus alba L.) and silkworms (Bombyx mori L.). J Agric Food Chem 49: 4208-4213 (2001)
20. Kim YM, Wang MH, Rhee HI. A novel alpha-glucosidase inhibitor from pine bark. Carbohydr Res 339: 715-717 (2004)
21. Stein DC, Kopec LK, Yasbin RE, Young FE. Characterization of Bacillus subtilis DSM704 and its production of 1-deoxynojirimycin. Appl Environ Microbiol 48: 280-284 (1984)
22. Shibano M, Fujimoto Y, Kushino K, Kusano G, Baba K. Biosynthesis of 1-deoxynojirimycin in Commelina communis: a difference between the microorganisms and plants. Phytochemistry 65: 2661-2665 (2004)
23. Scudder PR, Dwek RA, Rademacher TW, Jacob GS (US 5043273: Monsanto Company) Phosphorylated glycosidase inhibitor prodrugs, EP 413674, (1991)
24. Ridley CP, Bergquist PR, Harper MK, Faulkner DJ, Hooper JN, Haygood MG. Speciation and biosynthetic variation in four dictyoceratid sponges and their cyanobacterial symbiont, Oscillatoria spongeliae. Chem Biol 12: 397-406 (2005)